-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Corteva, Raises Price Target to $89

Benzinga·08/03/2026 20:38:51
语音播报
UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and raises the price target from $86 to $89.